Products

RightEye Vision System
RightEye
Neurology AI
RightEye Vision System is an advanced eye-tracking technology that objectively measures and analyzes eye movements to provide insights into visual function, brain health, and athletic performance, aiding in diagnosis and personalized therapy.

See all 1 product →

About RightEye

RightEye is a healthcare AI company that has developed a cutting-edge, non-invasive eye-tracking system designed to revolutionize patient care and improve vision performance. The company’s patented cloud-based software platform leverages advanced eye-tracking technology and artificial intelligence to objectively measure and analyze dynamic eye movements in real-time. This goes beyond traditional vision tests by evaluating functional aspects of vision, providing critical insights into a patient’s visual skills, brain health, and overall performance.

For physicians, the RightEye Vision System offers a unique diagnostic tool to detect hard-to-diagnose conditions and visual tracking impairments that often go unnoticed in routine exams. It provides quantifiable, visual, and automated reports that can help identify issues related to functional vision, brain health (including potential indicators for concussions, traumatic brain injury, and Parkinson’s disease), reading difficulties (such as those associated with dyslexia), and sports vision performance. The system also offers computer-based vision exercises to address oculomotor issues and can track patient progress over time, enabling tailored therapy sessions and more effective treatment plans. The RightEye system received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in October 2018 for recording, viewing, and analyzing eye movements to identify visual tracking impairment, and later received Breakthrough Device Designation from the FDA for its Parkinson’s disease test.

RightEye’s technology is utilized across various healthcare settings, from optometrists and ophthalmologists to neurologists and sports performance specialists. The goal is to provide earlier and more accurate detection and intervention for a range of health and performance issues, ultimately leading to better patient outcomes, lower costs, and improved quality of life.

Focus Areas

Functional Vision Screening Reading Assessments Sports Vision Assessment & Training Brain Health Concussion Assessment Traumatic Brain Injury (TBI) Parkinson's Disease Autism Detection (early indicators) Oculomotor Dysfunction Eye Teaming Visual Tracking Balance Hand-Eye Coordination

Business Intelligence

Key InvestorsCR2 Capital Ventures, VSP Vision
PartnershipsTobii, Major League Baseball (MLB), Bolton Optometry Clinic, Coldwater Vision Center
AcquisitionsNone reported
TechnologyCloud-based software platform, eye-tracking technology (high-speed infrared cameras and advanced software), AI/algorithms, gamified features
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Functional Vision Screening
RightEye offers a non-invasive, 5-minute test that objectively measures and analyzes eye movements to identify functional vision issues beyond standard 20/20 eyesight. It uncovers problems with eye focusing, teaming, and movement that impact daily activities and quality of life.
Reading Assessments
The system identifies reading disorders by tracking eye movements during reading tasks, analyzing metrics like words per minute, fixations, saccades, and regressions. It helps differentiate eye movement issues from other reading difficulties, aiding in early and appropriate intervention for conditions like dyslexia and learning challenges.
Sports Vision Assessment & Training
RightEye enhances athletic performance by assessing visual skills crucial for sports, including tracking fast-moving objects, improving reaction time, hand-eye coordination, depth perception, and spatial awareness. It provides personalized vision training programs based on assessment results.
Brain Health & Neurological Conditions (Concussion, TBI, Parkinson's, Autism)
RightEye serves as a diagnostic tool for brain health, concussion assessment, and traumatic brain injury (TBI) by identifying subtle changes in eye function and movement patterns often affected by head injuries. It detects ocular tremors in Parkinson's disease for faster diagnosis and aids in early autism detection by analyzing eye-tracking behaviors. It helps monitor recovery progress and supports rehabilitation.
Oculomotor Dysfunction, Eye Teaming, Visual Tracking, Balance, Hand-Eye Coordination
The technology precisely measures and analyzes various eye movements, including saccades, smooth pursuits, and fixation stability, to detect irregularities in how eyes move, track objects, and work together. This helps diagnose conditions like strabismus, nystagmus, amblyopia, and convergence insufficiency, which can affect balance and coordination.
Physician Tip

RightEye provides objective, quantifiable data on eye movements and visual function, offering insights beyond traditional eye charts. Physicians can leverage this for early detection and diagnosis of a wide range of visual and neurological conditions, leading to more targeted and personalized treatment plans. The quick, non-invasive 5-minute tests are easy to integrate into existing workflows and generate immediate, easy-to-understand reports. This allows for efficient patient assessment, progress monitoring during therapy, and differentiation of practice by offering advanced diagnostic capabilities. Furthermore, the system's insurance reimbursability makes it accessible to a broader patient base.

RightEye utilizes advanced eye-tracking technology, specifically integrating with Tobii eye-tracking hardware, combined with sophisticated software algorithms to process eye movement data. The system is designed for seamless integration into existing patient workflows, providing real-time, cloud-based reports that can be easily shared with patients and other healthcare professionals.

Products by RightEye

1 product in the directory

RightEye Vision System
RightEye
Neurology AI
RightEye Vision System is an advanced eye-tracking technology that objectively measures and analyzes eye movements to provide insights into visual function, brain health, and athletic performance, aiding in diagnosis and personalized therapy.

What the Web Says

RightEye is a company that develops eye-tracking technology for various applications, including health, vision, and performance. Reviews indicate that their products are generally seen as innovative and user-friendly, offering valuable insights for clinicians and trainers. However, some users have noted concerns regarding pricing and the need for more widespread adoption and integration.

Overall: Positive

Strengths

  • Innovative eye-tracking technology with diverse applications (health, vision, performance)
  • User-friendly interface and easy to administer tests
  • Provides objective data for concussion assessment and vision training
  • Valuable tool for identifying subtle vision issues and tracking progress
  • Potential for early detection of neurological conditions
  • Positive impact on patient care and athletic performance improvement

Limitations

  • High cost of the system can be a barrier for smaller practices
  • Limited integration with existing EMR/EHR systems
  • Requires dedicated training for staff to operate effectively
  • Some users desire more in-depth reporting and customization options
  • Relatively new technology, so long-term efficacy studies are still emerging
  • Customer support responsiveness can be inconsistent according to some reviews

Based on reviews from: G2, Glassdoor, Capterra, Healthcare IT News, Reddit, MobiHealthNews

Last updated: 2026-07-18

Videos

News, demos, and interviews about RightEye.

Loading videos...

Videos load interactively. If none appear, search YouTube for RightEye →

View all on YouTube

Press & Coverage

Glance by Eyes On Eyecare
FDA warns RightEye of violations with vision system - Glance by Eyes On Eyecare
The FDA issued a Warning Letter to RightEye, LLC, on January 31, 2023, regarding the company's misbranding and adulteration of its RightEye Vision System. The FDA cited specific examples of RightEye's inaccurate device promotions, including claims that it could treat a range of neurological disorders and detect vision abnormalities related to ADHD, mTBI, or Parkinson's disease, for which the system was not cleared.
2023-02
BioWorld
FDA hammers Righteye for off-label promotion of visual impairment system | BioWorld
The FDA issued a warning letter to RightEye LLC in December 2022, primarily concerned with the off-label promotion of the RightEye Vision System for evaluating ocular tremors as a sign of Parkinson's disease. RightEye's CEO stated the company has taken measures to address the identified problems, including hiring regulatory consultants.
2023-02
Sheppard Mullin
FDA Issues Warning Letter to RightEye, LLC For Misbranding and Adulteration | Sheppard
The FDA's warning letter to RightEye in December 2022 detailed misbranding due to promotion beyond cleared indications and adulteration due to failure to conform with good manufacturing practice requirements. The FDA determined RightEye's responses to initial observations were inadequate and warned of potential regulatory actions if violations are not addressed.
2023-02
Business Wire
RightEye Launches Eye Care's First Automated Sensorimotor Exam for Binocular Vision Testing - Business Wire
RightEye LLC launched the world's first automated, quantitative sensorimotor exam system for eye care professionals to objectively identify and address binocular vision issues and oculomotor dysfunction. This new technology aims to improve patient care and increase practice revenue by providing an efficient and reimbursable examination.
2021-08
Eye Care Network
Company debuts automated sensorimotor exam system | Eye Care Network
RightEye Sensorimotor, an automated, quantitative sensorimotor exam system, was launched to help ophthalmologists and optometrists identify and address binocular vision issues and oculomotor dysfunction. The system is designed to be easily integrated into existing practice workflows and is insurance reimbursable.
2021-08
20/20 Magazine
RightEye Releases Whitepaper on Automated Sensorimotor System for Testing Binocular Vision Issues - 20/20 Magazine
RightEye released a whitepaper detailing how its Sensorimotor System can be used by eyecare professionals to test for Binocular Vision Disorders, which affect approximately a third of the American population. The automated system offers a fast, accurate, and objective way to screen and conduct comprehensive exams for these conditions.
2022-03
Modern Optometry
RightEye: New Research Demonstrates Reliability of Eye Tracking Data to Identify and Measure Severity of Traumatic Brain Injuries - - Modern Optometry
RightEye announced a study published in the peer-reviewed journal Concussion, demonstrating its FDA-cleared technology accurately measures eye movement deficits resulting from concussions. The study highlights the technology's ability to objectively differentiate between individuals with varying severities of concussion and guide recovery.
2019-08
Guided Solutions
RightEye Secures FDA 510(k) Clearance for Eye-Tracking Platform - Guided Solutions
RightEye received 510(k) clearance from the U.S. FDA for its eye-tracking technology to record, view, and analyze eye movement in support of identifying visual tracking impairment. This clearance is a significant regulatory milestone for the company, which has seen its technology adopted by optometrists, hospitals, and sports teams.
2018-10

Frequently Asked Questions

RightEye offers a suite of EyeQ tests, including Functional Vision EyeQ, Reading EyeQ, Sports Vision EyeQ, and Brain Health EyeQ, which utilize eye-tracking technology to measure and analyze eye movements. Additionally, they provide EyeQ Trainer, a program designed for computer-based vision exercises.
RightEye's system records, views, and analyzes eye movements to identify visual tracking impairments, which can provide objective data related to oculomotor dysfunction, eye teaming, and visual tracking. While the system can offer insights into visual skill problems associated with conditions like concussion, TBI, and Parkinson's, the FDA has issued a Warning Letter stating that the device is not cleared for diagnosing these specific neurological conditions or for improving vision problems.
RightEye's Vision System received FDA 510(k) clearance in 2018 for recording, viewing, and analyzing eye movements to identify visual tracking impairment in human subjects. However, in January 2023, the FDA issued a Warning Letter to RightEye for promoting the device beyond its cleared indications, specifically for diagnosing conditions like mild traumatic brain injury (mTBI), Parkinson's disease, or ADHD, and for claims of improving vision problems.
RightEye's Reading EyeQ tracks reading proficiency to identify hidden visual issues that may be associated with learning difficulties. While the company has explored aiding early autism detection, the FDA Warning Letter clarified that the device is not cleared for assessing or diagnosing neurodevelopmental conditions like ADHD or autism.
RightEye aims to expand services for healthcare professionals and offers resources to integrate their system into practice. They provide demonstrations and solutions advisors to discuss how the technology can benefit a practice, implying support for setup and usage.
RightEye has a significant partnership with Tobii, a leader in eye-tracking technology, which provides the hardware for RightEye's solutions. This collaboration enables the analysis of eye movement behavior and the generation of objective reports. RightEye has also partnered with organizations like Major League Baseball for sports vision assessments.
RightEye was founded in 2012 and has raised a total funding of $11.3M to $12.7M across multiple rounds, including Series A funding. The company operates as a provider of eye-tracking solutions for general healthcare and wellness.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.